US Stocks Movement | Argenx (ARGX.US) rises over 10% pre-market as Phase III study of autoimmune myositis drug Vyvgart meets primary endpoint
智通财经2026/08/17 11:01Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Golden Ten Data APP, before the U.S. stock market opened on Monday, the stock price of European biotechnology company Argenx (ARGX.US) surged by 10.38%. According to reports, the company announced on Monday that its autoimmune myositis drug Vyvgart reached the primary endpoint in a Phase III study.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Spot gold breaks through the $4,400/ounce mark, down 0.7% on the day
智通财经•2026/09/07 07:26
European semiconductor stocks rise, with STMicroelectronics and others up 1% to 3%
智通财经•2026/09/07 07:16
Crypto prices
More
Bitcoin
BTC
$79,490.07
-0.43%
Ethereum
ETH
$2,490.93
-0.20%
Tether USDt
USDT
$0.9999
-0.02%
BNB
BNB
$743.85
-1.78%
XRP
XRP
$1.41
-0.77%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$104.92
-0.23%
TRON
TRX
$0.3366
+0.91%
Hyperliquid
HYPE
$86.79
+0.92%
Zcash
ZEC
$1,196.32
+2.88%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now